Glossary

AJAX progress indicator
Search:
(clear)
  • Absorption
    In pharmacology and pharmacokinetics, absorption is the process whereby medicines are transported or taken up from the site of administration (by mouth, inhalation, intravenous or intramuscular injection, etc.) to the blood through capillary, osmotic, solvent, or chemical action in the cells.(...)
  • Absorption, Distribution, Metabolism, and Excretion
    Absorption, Distribution, Metabolism, and Excretion
  • Acquired Immunodeficiency Syndrome
    Acquired Immunodeficiency Syndrome (AIDS) is the group of conditions that develop during the advanced stage of  infection with the human immunodeficiency virus (HIV). People at this stage of HIV disease have badly damaged immune systems, which puts them at risk of infection. Patients(...)
  • Active molecule
    In medicines R&D an active molecule is a chemical compound that has pharmacological or biological activity likely to be therapeutically useful.
  • Active Pharmaceutical Ingredient
    Active Pharmaceutical Ingredient
  • Adaptive Design
    The option to modify the design of an ongoing clinical trial is becoming increasingly common and is known as adaptive design. Data are evaluated before the trial is finished. This is known as interim analysis and might be carried out at several time points. Depending on the circumstances, this(...)
  • Adherence
    In medicine, adherence describes the degree to which a patient correctly follows medical advice. Poor adherence is often associated with patients not following prescribed medicines and treatment regimes. Non-adherence or poor adherence has been reported as a major problem in medical practice(...)
  • ADME
    Absorption, Distribution, Metabolism, and Excretion
  • ADR
    A response to a medicinal product which is harmful and unintended. Response in this context means that a causal relationship between the medicinal product and an adverse event is at least a reasonable possibility. Adapted from the Guideline on good pharmacovigilance practices (GVP) Annex I -(...)
  • Advanced therapy medicinal products
    Advanced therapy medicinal products (ATMP) are new medical products for human use based on genes (gene therapy), cells (cell therapy), or tissues (tissue engineering). They have huge potential and open the way for new treatments of a number of diseases or injuries, such as skin in burns(...)
  • Adverse Drug Reaction
    A response to a medicinal product which is harmful and unintended. Response in this context means that a causal relationship between the medicinal product and an adverse event is at least a reasonable possibility. Adapted from the Guideline on good pharmacovigilance practices (GVP) Annex I -(...)
  • AIDS
    Acquired Immunodeficiency Syndrome (AIDS) is the group of conditions that develop during the advanced stage of  infection with the human immunodeficiency virus (HIV). People at this stage of HIV disease have badly damaged immune systems, which puts them at risk of infection. Patients(...)
  • API
    Active Pharmaceutical Ingredient
  • ATMP
    Advanced therapy medicinal products (ATMP) are new medical products for human use based on genes (gene therapy), cells (cell therapy), or tissues (tissue engineering). They have huge potential and open the way for new treatments of a number of diseases or injuries, such as skin in burns(...)
  • 'Me too' medicine
    ‘Me too’ medicines are products which have more or less identical clinical outcomes to existing medicines. They are compounds structurally very similar to already known medicines that have an identical mechanism of action with only minor pharmacological differences. They can present some(...)

Find Out More